Harmony Biosciences Holdings HRMY
NASDAQ HRMY
$39.64 +0.07 (+0.18%)
At close: Oct 2, 2026 · 4:00 PM EDT

Harmony Biosciences Holdings (HRMY) Return on Capital Employed [ROCE] (2020 - 2026)

Updated

Harmony Biosciences Holdings (HRMY) recorded Return on Capital Employed [ROCE] of 21.19% in Q2 2026, down 3.41 percentage points from 24.61% a year earlier but up 3.22 percentage points from the prior quarter.

Analysis

Harmony Biosciences Holdings (HRMY) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends

For FY2025, Harmony Biosciences Holdings reported Return on Capital Employed [ROCE] of 23.60%, down 2.53 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a five-year change of +10.77 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at 26.13% in FY2024 (-7.04 pp), 33.17% in FY2023 (+7.86 pp), 25.31% in FY2022 (+2.07 pp) and 23.25% in FY2021 (+10.41 pp).
  • Quarterly Return on Capital Employed [ROCE] has ranged from 17.97% in Q1 2026 to 30.44% in Q4 2023 over the past five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined for three consecutive quarters, with an average year-over-year change of -3.98 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 17.79 percentage points in Q4 2021, against a drop of 7.29 percentage points in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at 17.97% (Q1 2026), 21.10% (Q4 2025) and 24.14% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Harmony Biosciences Holdings 2.30 Bn -452.73 Mn 198.08 Mn 21.19%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.19%
Mar 31, 2026 17.97%
Dec 31, 2025 21.10%
Sep 30, 2025 24.14%
Jun 30, 2025 24.61%
Mar 31, 2025 22.89%
Dec 31, 2024 24.20%
Sep 30, 2024 23.95%
Jun 30, 2024 25.22%
Mar 31, 2024 30.17%
Dec 31, 2023 30.44%
Sep 30, 2023 30.38%
Jun 30, 2023 22.78%
Mar 31, 2023 21.84%
Dec 31, 2022 20.73%
Sep 30, 2022 21.68%
Jun 30, 2022 26.35%
Mar 31, 2022 25.64%
Dec 31, 2021 24.42%
Sep 30, 2021 20.34%
API Access

Harmony Biosciences Holdings Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=HRMY&period=max&api_key=YOUR_API_KEY